MobiHealth News April 3, 2025
Anthony Vecchione

Noom teams up with LillyDirect pharmacy provider Gifthealth to offer access to single-dose vials of Zepbound.

Diet weight loss company Noom has entered into an agreement with Eli Lilly’s LillyDirect pharmacy provider Gifthealth to help improve access to FDA-approved Zepbound (tirzepatide) single-dose vials for Noom’s members with an on-label prescription from a doctor.

The integration with the LillyDirect pharmacy provider expands Noom’s approach to weight management by allowing an option for members whose doctors prescribe FDA-approved medications.

The new product integration will be available to members in mid-April.

In a statement, Noom said it provides a GLP-1 companion to support members with making health a habit alongside taking their medication.

Members will get a GLP-1 Med Tracker with...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Pharma / Biotech
Pharma Dodges The Tariff Bullet — But For How Long?
PBM Private Labeling Boosts Biosimilars, Raises Concerns
Q&A: How can drug repurposing lower drug costs and improve care?
BC researchers receive $49M for genomics projects
Biotech ‘megarounds’ hold steady as startups, VCs wait on IPOs

Share This Article